# ALBENDAZOLE
> **ANDA210434** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2018-09-21
## Drug
- **FDA Application Number:** ANDA210434
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ALBENDAZOLE
- **Generic name:** Albendazole
- **Active ingredients:** ALBENDAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CIPLA LTD
- **First approval:** 2018-09-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210434)
---
*MORVS · CC0 1.0*